# Third Party Viral Specific T-cells (VSTs)

> **NCT02532452** · PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 750 (estimated)

## Conditions studied

- Viral Infection
- Viral Reactivation
- Infection in an Immunocompromised Host

## Interventions

- **BIOLOGICAL:** Viral Specific VST Infusion

## Key facts

- **NCT ID:** NCT02532452
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-09-02
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532452, "Third Party Viral Specific T-cells (VSTs)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02532452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*